StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTIQ) income statement

KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Karyopharm Therapeutics Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-56.2%
Net margin
-153.3%
Return on equity, FY2025
81.9%

Financial strength

Current ratio
0.79
Debt to equity
–
Debt to assets
–
Cash to current liabilities
41.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

Valuation ratios need the share price and fill in once daily prices are connected.

See a number that looks wrong?